H. Lundbeck A/S (HLBBF)
PNK: HLBBF
· Real-Time Price · USD
5.10
0.68 (15.52%)
At close: May 01, 2025, 3:14 PM
15.52% (1D)
| Bid | 4.35 |
| Market Cap | 4.04B |
| Revenue (ttm) | 22.03B |
| Net Income (ttm) | 3.14B |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 10.62 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 5.27 |
| Volume | 200 |
| Avg. Volume (20D) | 67 |
| Open | 5.10 |
| Previous Close | 4.42 |
| Day's Range | 5.10 - 5.10 |
| 52-Week Range | 4.42 - 7.50 |
| Beta | 0.27 |
About HLBBF
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine p...
Sector Healthcare
IPO Date Jul 13, 2022
Employees 5,707
Stock Exchange PNK
Ticker Symbol HLBBF
Website https://www.lundbeck.com